ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Pharmaceutical Research And Manufacturers Of America

Official 2024 U.S. DOL Form 5500 summary for Pharmaceutical Research And Manufacturers Of America (Pharmaceutical Research And Manufacturers Of America Deferred Savings Plan · EIN 53-0241211 · PN 002): $125.91M net assets, 235 active participants, and $3.25 per $10,000 (3.25 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorPharmaceutical Research And Manufacturers Of America
Filing IdentifierPharmaceutical Research And Manufacturers Of America Deferred Savings Plan · EIN 53-0241211 · PN 002
Plan Category & State401(k) Defined Contribution (DC)
Asset-Size Peer Cohort$100M-$500M
Plan Net Assets (2024)$125.91M
Active Participants235
Direct Admin Fee Rate$3.25 per $10,000 (3.25 bps)
Cohort Peer Median$9.75 per $10,000 (9.75 bps)
Primary Recordkeeper / ProviderPrincipal Financial Group
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI